John Overdeck’s Pharvaris PHVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.49M Buy
216,640
+90,564
+72% +$2.74M 0.01% 1763
2026
Q1
$3.56M Sell
126,076
-89,112
-41% -$2.38M ﹤0.01% 2292
2025
Q4
$5.97M Buy
215,188
+204,581
+1,929% +$4.93M 0.01% 1557
2025
Q3
$265K Buy
+10,607
New +$235K ﹤0.01% 3271
2024
Q1
Sell
-8,198
Closed -$230K 3294
2023
Q4
$230K Buy
+8,198
New +$166K ﹤0.01% 2778

Other funds holding PHVS

John Overdeck's PHVS Position: Q2 2026 in Review

John Overdeck increased its Pharvaris (PHVS) stake by 72% in Q2 2026, buying an estimated $2.74M and bringing the position to 216,640 shares worth $7.49M. The position accounts for 0.01% of the portfolio, ranked #1763.

John Overdeck first reported a position in PHVS in Q4 2023 and has held it in 5 quarters since. 124 funds tracked by Wall St. Rank hold PHVS as of Q2 2026.

  • John Overdeck held 216,640 shares of Pharvaris worth $7.49M as of Q2 2026.
  • John Overdeck bought 90,564 Pharvaris shares in Q2 2026, an estimated $2.74M.
  • Pharvaris made up 0.01% of John Overdeck's portfolio in Q2 2026, its #1763 holding.
  • John Overdeck first reported a position in Pharvaris in Q4 2023 and has held it in 5 quarters since.
  • 124 funds tracked by Wall St. Rank held Pharvaris as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.